Avidity Partners Management LP 13D and 13G filings for Fusion Pharmaceuticals Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-13 9:34 pm Sale | 2023-12-31 | 13G | Fusion Pharmaceuticals Inc. FUSN | Avidity Partners Management LP | 6,500,328 8.100% | -324,122 (-4.75%) | Filing |
| 2023-10-23 5:20 pm Purchase | 2023-10-18 | 13G | Fusion Pharmaceuticals Inc. FUSN | Avidity Partners Management LP | 6,824,450 9.700% | 6,824,450 (New Position) | Filing |